Home > Boards > US Listed > Biotechs >

Baudax Bio Inc (BXRX)

Add BXRX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/18/2022 8:01:06 AM - Followers: 20 - Board type: Free - Posts Today: 0

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Its lead product candidate (in fact just  approved by FDA on the 07th of April) is intravenous form of meloxicam, a non-opioid that has completed Phase III clinical trials for the management of moderate to severe pain; and is in the Phase IIIb clinical trials in colorectal surgery and orthopedic surgery patients to assess opioid consumption, pain intensity, and length of hospital stay with associated pharmacoeconomic parameters. The company's early-stage product candidates includes RP1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; and RP2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and a reversal agent, as well as Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.
Received in February 2020 an NDA for their drug - ANJESO :
ANJESO Is The Only Approved 24-Hour, Intravenous COX-2 Preferential NSAID that Offers Once-Daily Dosing
Full Commercial Launch Expected to Commence by June 2020
MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that ANJESO™ (meloxicam) injection, the only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory drug (NSAID), is now available for ordering and delivery to customers.  ANJESO was approved by the U.S. Food and Drug Administration (FDA) on February 20, 2020 and is indicated for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. 
We are diligently working to hire and train our field sales force and expect to execute the full ANJESO commercial launch by later in the 2nd quarter.”
Article on Anjeso:
Raising capital for commercialization phase:
Cash (before warrants potential conversion at  $3.25 and $4.59) :
Raised $25M on March 24th 2020
Had $17M in cash as of Dec 31st 2019

Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that, as part of its overall capital financing strategy to fund the Company and the upcoming commercial launch of ANJESO, it has signed a non-binding term sheet with an undisclosed party for a secured term loan for up to $20 million in non-dilutive funding over the next 12 to 18 months.

Baudax expects to close this debt financing transaction in the next 4 to 8 weeks.

Shares outstanding:
March 26, 2020 17.57M

Insider buying:

CHURCHILL WINSTON J Director Mar 26 Buy 2.28 6,500 14,820 6,500 Mar 30 08:00 PM
CHURCHILL WINSTON J Director Mar 26 Buy 2.44 25,000 61,000 52,782 Mar 30 08:00 PM
Weisman Wayne Director Mar 26 Buy 2.29 10,000 22,900 40,582 Mar 27 03:53 PM
ALTOMARI ALFRED Director Mar 26 Buy 2.34 5,000 11,700 33,382 Mar 27 03:51 PM



Janney starts Baudax Bio at buy; fair value estimate $12
Baudax’s key product is Anjeso, a long-acting intravenous formulation of meloxicam, an established non-opioid pain reliever, available through an oral formulation. “We see a high probability of FDA approval in the first quarter of 2020, which would be a meaningful catalyst to drive the stock towards our fair value,” writes analyst Ester Hong.
She estimates peak U.S. sales of $355-million for Anjeso but sees “upside from increased demand for a potent non-opioid that allows patients to recover and go home faster.”
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BXRX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 02:08 AM
BXRX News: Current Report Filing (8-k) 05/18/2022 12:43:58 PM
BXRX News: Baudax Bio to Present at the H.C. Wainwright Annual Global Life Sciences Conference 05/18/2022 04:00:00 AM
BXRX News: Baudax Bio Announces $2.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 05/17/2022 03:00:00 PM
BXRX News: Analysts Offer Insights on Healthcare Companies: Baudax Bio (BXRX) and Axcella Health (AXLA) 05/06/2022 04:05:31 AM
News News Alert: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 05/19/2022 02:08:00 AM
#177   The Annual Meeting will reconvene at 9:00 a.m. BooDog 05/18/22 08:01:06 AM
#176   Took some 1.25's and 6's. BooDog 05/06/22 02:53:51 PM
#175   The sky isn't falling. Just the low BooDog 05/05/22 11:01:12 AM
#174   Still accumulating a bit here. The up BooDog 03/29/22 10:16:17 AM
#173   Baudax Bio Initiates Phase IV Clinical Trial Evaluating BooDog 03/08/22 08:38:38 AM
#172   Wow. Any takers? BooDog 02/25/22 07:51:30 AM
#171   Offering announced. I didn't see a price punched BooDog 02/24/22 05:04:56 PM
#170   Splits. They're so predictable imo. Probably BooDog 02/16/22 02:00:29 PM
#169   INDEFATIGABLE DUMPING! Disquisition 02/16/22 10:23:49 AM
#168   R/S 35 = 1 Still watch kzivann 02/16/22 07:30:25 AM
#167   $0.256 $0.06 (30.35%) Vol 6.4M Heavy Day BooDog 01/20/22 06:41:18 AM
#166   Yes, they've stated that as one of the BooDog 01/10/22 03:46:18 PM
#165   R/S on table .. watch kzivann 01/10/22 08:06:48 AM
#164   Correction: the sabby reference is not for BXRX. BooDog 01/04/22 08:35:38 AM
#163   I have two things on my mind here. BooDog 01/04/22 08:10:09 AM
#162   Up pressure building nicely. Inverted head and BooDog 12/09/21 12:13:39 PM
#161   They'll get there. I'm still accumulating thinking BooDog 11/04/21 09:16:31 AM
#160   BXRX bigger than expected loss. kzivann 11/04/21 08:07:42 AM
#159   I have to say, I like the looks BooDog 11/04/21 07:31:09 AM
#158   LII's like the .58 for support. I'll BooDog 10/27/21 10:44:14 AM
#157   Looks like a squeeze! See what she's got! BooDog 10/27/21 10:18:30 AM
#156   CEO buys, I buy. My last buy BooDog 09/24/21 08:37:52 AM
#155   dojihttps://www.stockscores.com/chart.asp?TickerSymbol=%20bxrx&TimeRange=365&Interval=w& The Night Stalker 09/10/21 06:59:00 PM
#154   https://www.stockscores.com/chart.asp?TickerSymbol=%20bxrx&TimeRange=365&Interva The Night Stalker 09/10/21 06:59:00 PM
#153   strong The Night Stalker 09/07/21 07:35:25 PM
#152   https://www.stockscores.com/chart.asp?TickerSymbol=%20bxrx&TimeRange=365&Interva The Night Stalker 09/07/21 07:35:25 PM
#151   strong The Night Stalker 09/02/21 09:47:47 PM
#150   https://www.stockscores.com/chart.asp?TickerSymbol=%20bxrx&TimeRange=365&Interva The Night Stalker 09/02/21 09:47:47 PM
#149   What are the rumors for all the volume? redspinelpinktopaz 09/02/21 11:22:42 AM
#148   https://www.stockscores.com/chart.asp?TickerSymbol=%20bxrx&TimeRange=365&Interva The Night Stalker 09/01/21 07:16:01 PM
#147   https://www.stockscores.com/chart.asp?TickerSymbol=%20bxrx&TimeRange=365&Interva The Night Stalker 08/31/21 05:19:18 PM
#146   BXRX https://twitter.com/TraderTexMex/status/1432814040808574976 G2G 08/31/21 05:15:12 PM
#145   strong The Night Stalker 08/25/21 05:17:13 PM
#144   $2 Gap waiting to get taken out imo SmokeSignals 08/24/21 02:30:08 PM
#143   Thanks for the alert Night Stalker! I didn't BooDog 08/24/21 06:30:58 AM
#142   Early volume! BooDog 08/24/21 05:38:29 AM
#141   nice The Night Stalker 08/23/21 07:49:44 PM
#140   Time to Load the Boat Daytrader0001 06/11/21 02:33:23 PM
#139   Buying. Form 4. Missed this from BooDog 06/11/21 06:13:21 AM
#138   BXRX cup and handle. BooDog 05/19/21 03:15:08 PM
#137   Looking for the dead cat bounce. BooDog 05/06/21 11:32:46 AM
#136   Form 4 @ 1.40. CFO added. https://ih.advfn.com/stock-market/NASDAQ/baudax-bio-BXRX/stock-news/84596 BooDog 03/16/21 06:08:27 PM
#135   How long does their cash last? mining101 03/04/21 07:52:53 AM
#134   kind of a shitty low quality call yesterday janeyH 02/17/21 07:50:29 AM
#133   Stonepine is out. BooDog 02/13/21 05:34:25 PM
#132   Had to know an offering was coming. BooDog 02/08/21 04:43:37 PM
#131   you've got the right name for today's action janeyH 02/08/21 04:03:31 PM
#130   Boom HeavenandHell 02/08/21 02:12:24 PM
#129   [/Baudax Bio is a pharmaceutical company focused on alwaysthankfull 01/19/21 01:42:41 PM
#128   Solid consolidating 1.20's to 1.30's. going to Deano361 01/13/21 09:11:49 PM
Consent Preferences